Market Overview

Endo Health Solutions to Buy Boca Pharmacal for $225M

Share:
Related ENDP
Watch These 4 Huge Put Purchases In Wednesday Trade
Endo International Sharply Higher
10 Biotech And Specialty Pharma Bargains-Do You Have The Guts To Speculate? (Seeking Alpha)

Endo Health Solutions (NASDAQ: ENDP) today announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for $225 million in cash.  The transaction is expected to enhance the growth platform and pipeline for Endo's Qualitest business and is consistent with Endo's strategic transformation into a leading specialty healthcare company.

Posted-In: News M&A

 

Related Articles (ENDP)

View Comments and Join the Discussion!